An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 M


Journal

Cell chemical biology
ISSN: 2451-9448
Titre abrégé: Cell Chem Biol
Pays: United States
ID NLM: 101676030

Informations de publication

Date de publication:
16 12 2021
Historique:
received: 26 11 2020
revised: 24 03 2021
accepted: 27 05 2021
pubmed: 27 6 2021
medline: 6 1 2022
entrez: 26 6 2021
Statut: ppublish

Résumé

Designing covalent inhibitors is increasingly important, although it remains challenging. Here, we present covalentizer, a computational pipeline for identifying irreversible inhibitors based on structures of targets with non-covalent binders. Through covalent docking of tailored focused libraries, we identify candidates that can bind covalently to a nearby cysteine while preserving the interactions of the original molecule. We found ∼11,000 cysteines proximal to a ligand across 8,386 complexes in the PDB. Of these, the protocol identified 1,553 structures with covalent predictions. In a prospective evaluation, five out of nine predicted covalent kinase inhibitors showed half-maximal inhibitory concentration (IC

Identifiants

pubmed: 34174194
pii: S2451-9456(21)00263-4
doi: 10.1016/j.chembiol.2021.05.018
pmc: PMC8228784
pii:
doi:

Substances chimiques

Protein Kinase Inhibitors 0
Viral Matrix Proteins 0
membrane protein, SARS-CoV-2 0
Acrylamide 20R035KLCI

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1795-1806.e5

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests N.L. is a member of the SAB of Totus medicines, Monte Rosa Therapeutics and MetaboMed.

Références

J Cheminform. 2019 Jan 3;11(1):1
pubmed: 30604073
Bioorg Med Chem Lett. 2019 Jan 1;29(1):36-39
pubmed: 30455147
J Am Chem Soc. 2016 Aug 24;138(33):10554-60
pubmed: 27478969
J Med Chem. 2019 Mar 14;62(5):2428-2446
pubmed: 30742435
J Med Chem. 2015 Jun 11;58(11):4790-801
pubmed: 25977981
Biochemistry. 2019 Dec 31;58(52):5234-5244
pubmed: 30990686
Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2070-5
pubmed: 18227510
J Chem Inf Model. 2018 Jul 23;58(7):1441-1458
pubmed: 29890081
Nat Chem Biol. 2014 Dec;10(12):1066-72
pubmed: 25344815
Nucleic Acids Res. 2020 Jan 8;48(D1):D344-D353
pubmed: 31584092
Metab Eng. 2018 Jan;45:158-170
pubmed: 29233745
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
J Chem Inf Model. 2019 Aug 26;59(8):3565-3571
pubmed: 31246457
Nat Chem Biol. 2019 Mar;15(3):250-258
pubmed: 30643284
Nat Commun. 2017 Apr 24;8:15123
pubmed: 28436492
Nat Chem Biol. 2015 Jul;11(7):525-31
pubmed: 26006010
J Med Chem. 2014 Jun 12;57(11):4969-74
pubmed: 24870364
Nature. 1998 May 28;393(6683):392-6
pubmed: 9620806
Viruses. 2021 Jan 25;13(2):
pubmed: 33503819
ACS Chem Biol. 2016 Dec 16;11(12):3442-3451
pubmed: 27791347
J Am Chem Soc. 2015 Oct 7;137(39):12442-5
pubmed: 26371805
Angew Chem Int Ed Engl. 2018 May 4;57(19):5257-5261
pubmed: 29480525
Curr Opin Chem Biol. 2016 Oct;34:110-116
pubmed: 27599186
J Med Chem. 2017 Mar 9;60(5):1793-1816
pubmed: 28140585
J Med Chem. 2013 Jan 24;56(2):534-46
pubmed: 23231439
J Med Chem. 2018 Jul 12;61(13):5719-5732
pubmed: 29883107
J Clin Oncol. 2016 Oct 1;34(28):3375-82
pubmed: 27354477
J Clin Oncol. 2013 Sep 20;31(27):3327-34
pubmed: 23816960
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):133-44
pubmed: 20124693
Nature. 2016 Jun 15;534(7608):570-4
pubmed: 27309814
J Med Chem. 2019 Sep 12;62(17):7643-7655
pubmed: 31368705
Bioorg Med Chem. 2008 Apr 1;16(7):3482-8
pubmed: 18316192
ChemMedChem. 2019 May 6;14(9):889-906
pubmed: 30816012
Nature. 2019 Nov;575(7781):217-223
pubmed: 31666701
J Med Chem. 2014 Dec 11;57(23):10072-9
pubmed: 25375838
Nat Chem. 2020 Jul;12(7):581
pubmed: 32555379
J Chem Inf Model. 2010 Jun 28;50(6):979-91
pubmed: 20536191
Int J Biol Macromol. 2018 May;111:1175-1182
pubmed: 29371148
Cell Chem Biol. 2017 Aug 17;24(8):1005-1016.e3
pubmed: 28781124
Nat Chem Biol. 2014 Oct;10(10):853-60
pubmed: 25195011
Angew Chem Int Ed Engl. 2019 Jan 8;58(2):515-519
pubmed: 30431220
ChemMedChem. 2019 May 17;14(10):1011-1021
pubmed: 30786178
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
J Chem Inf Model. 2011 Oct 24;51(10):2768-77
pubmed: 21932860
J Am Chem Soc. 2019 Feb 13;141(6):2703-2712
pubmed: 30657686
Bioorg Med Chem. 2016 Mar 15;24(6):1384-91
pubmed: 26897089
Cancer Discov. 2015 Apr;5(4):424-37
pubmed: 25776529
J Chem Inf Model. 2019 Apr 22;59(4):1472-1485
pubmed: 30908019
J Chem Inf Model. 2017 Dec 26;57(12):3124-3137
pubmed: 29131621
J Med Chem. 2015 Sep 10;58(17):6844-63
pubmed: 26275028
Science. 2020 Apr 24;368(6489):409-412
pubmed: 32198291
J Med Chem. 1996 Jul 19;39(15):2887-93
pubmed: 8709122
Bioorg Med Chem Lett. 2015 Nov 1;25(21):4728-4732
pubmed: 26338362
J Med Chem. 2019 Jan 24;62(2):1054-1066
pubmed: 30615446
Acta Crystallogr D Struct Biol. 2017 Feb 1;73(Pt 2):112-122
pubmed: 28177307
Chem Soc Rev. 2018 Jun 5;47(11):3816-3830
pubmed: 29620097
Angew Chem Int Ed Engl. 2015 Dec 21;54(52):15888-91
pubmed: 26563572
Science. 2005 May 27;308(5726):1318-21
pubmed: 15919995
J Med Chem. 2020 May 28;63(10):5102-5118
pubmed: 32083858
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):293-302
pubmed: 21460447
Cell. 2017 Jan 26;168(3):527-541.e29
pubmed: 28111073
Acta Crystallogr D Struct Biol. 2017 Mar 1;73(Pt 3):267-278
pubmed: 28291762
J Chem Inf Model. 2018 Feb 26;58(2):464-471
pubmed: 29320178
Curr Top Microbiol Immunol. 2019;420:375-417
pubmed: 30105421
Cell Chem Biol. 2019 Jan 17;26(1):98-108.e5
pubmed: 30449673
J Cheminform. 2009 Jun 10;1(1):8
pubmed: 20298526
Nature. 2020 Jun;582(7811):289-293
pubmed: 32272481
RSC Med Chem. 2020 Jul 2;11(8):876-884
pubmed: 33479682
Leuk Lymphoma. 2013 Nov;54(11):2385-91
pubmed: 23425038
J Med Chem. 2016 May 26;59(10):4711-23
pubmed: 27187609
J Chem Inf Model. 2014 Jul 28;54(7):1941-50
pubmed: 24932913
Structure. 2013 Feb 5;21(2):209-19
pubmed: 23273428
Proc Natl Acad Sci U S A. 2000 Sep 12;97(19):10383-8
pubmed: 10984534
Bioorg Med Chem. 2015 Oct 1;23(19):6520-7
pubmed: 26358279
J Am Chem Soc. 2019 Jun 5;141(22):8951-8968
pubmed: 31060360
J Chem Inf Model. 2020 Sep 28;60(9):4388-4402
pubmed: 32233478
Acta Crystallogr D Struct Biol. 2018 Feb 1;74(Pt 2):85-97
pubmed: 29533234
J Chem Inf Model. 2020 Jun 22;60(6):2915-2923
pubmed: 32250627
J Chem Inf Comput Sci. 1998 May-Jun;38(3):511-22
pubmed: 9611787
J Chem Inf Model. 2009 Mar;49(3):593-602
pubmed: 19434897
Angew Chem Int Ed Engl. 2015 Aug 24;54(35):10313-6
pubmed: 26110718
Nat Commun. 2020 Oct 7;11(1):5047
pubmed: 33028810
Acta Crystallogr D Biol Crystallogr. 2013 Jul;69(Pt 7):1260-73
pubmed: 23793152
Angew Chem Int Ed Engl. 2019 Jan 21;58(4):957-966
pubmed: 30024079
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508
Curr Opin Chem Biol. 2015 Feb;24:18-26
pubmed: 25461720

Auteurs

Daniel Zaidman (D)

Department of Chemical and Structural Biology, Weizmann Institute of Science, 7610001 Rehovot, Israel.

Paul Gehrtz (P)

Department of Chemical and Structural Biology, Weizmann Institute of Science, 7610001 Rehovot, Israel.

Mihajlo Filep (M)

Department of Chemical and Structural Biology, Weizmann Institute of Science, 7610001 Rehovot, Israel.

Daren Fearon (D)

Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot OX11 0QX, UK.

Ronen Gabizon (R)

Department of Chemical and Structural Biology, Weizmann Institute of Science, 7610001 Rehovot, Israel.

Alice Douangamath (A)

Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot OX11 0QX, UK.

Jaime Prilusky (J)

Life Sciences Core Facilities, Weizmann Institute of Science, 7610001 Rehovot, Israel.

Shirly Duberstein (S)

Wohl Institute for Drug Discovery of the Nancy and Stephen Grand Israel National Center for Personalized Medicine, The Weizmann Institute of Science, 7610001 Rehovot, Israel.

Galit Cohen (G)

Wohl Institute for Drug Discovery of the Nancy and Stephen Grand Israel National Center for Personalized Medicine, The Weizmann Institute of Science, 7610001 Rehovot, Israel.

C David Owen (CD)

Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot OX11 0QX, UK; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, UK.

Efrat Resnick (E)

Department of Chemical and Structural Biology, Weizmann Institute of Science, 7610001 Rehovot, Israel.

Claire Strain-Damerell (C)

Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot OX11 0QX, UK; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, UK.

Petra Lukacik (P)

Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot OX11 0QX, UK; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, UK.

Haim Barr (H)

Wohl Institute for Drug Discovery of the Nancy and Stephen Grand Israel National Center for Personalized Medicine, The Weizmann Institute of Science, 7610001 Rehovot, Israel.

Martin A Walsh (MA)

Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot OX11 0QX, UK; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, UK.

Frank von Delft (F)

Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot OX11 0QX, UK; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, UK; Structural Genomics Consortium, University of Oxford, Old Road Campus, Roosevelt Drive, Headington OX3 7DQ, UK; Department of Biochemistry, University of Johannesburg, Auckland Park 2006, South Africa.

Nir London (N)

Department of Chemical and Structural Biology, Weizmann Institute of Science, 7610001 Rehovot, Israel. Electronic address: nir.london@weizmann.ac.il.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH